NCT03418961 S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity Status RECRUITING Phase PHASE3
NCT03389724 Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia Status COMPLETED Phase PHASE3
NCT03186404 Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study Status UNKNOWN Phase PHASE2
NCT03155802 Novel Biomarkers and Echocardiography for Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving Anthracyclines Status UNKNOWN Phase N/A
NCT03038997 Early Detection of Cardiac Toxicity in Childhood Cancer Survivors Status TERMINATED Phase N/A
NCT02942615 The Safety Management of Cardiac Toxicity in Breast Cancer Patients Under Multidiscipline Therapy. Status ACTIVE_NOT_RECRUITING Phase NA
NCT02909712 Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania Status COMPLETED Phase PHASE2
NCT02798679 Cardiac Fibrosis and Risk Prediction in Cancer Treatment-Related Cardiotoxicity Status COMPLETED Phase N/A
NCT02236806 Cardiotoxicity Prevention in Breast Cancer Patients Treated With Anthracyclines and/or Trastuzumab Status UNKNOWN Phase PHASE3
NCT01724450 Carvedilol Effect in Preventing Chemotherapy - Induced Cardiotoxicity Status COMPLETED Phase PHASE3
NCT01665300 Usefulness of Myocardial Deformation Imaging for Trastuzumab-induced Cardiotoxicity Status COMPLETED Phase N/A